# PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer

> **NCT06392295** · PHASE2 · RECRUITING · sponsor: **University of Miami** · enrollment: 34 (estimated)

## Conditions studied

- Prostate Cancer
- Prostate Adenocarcinoma
- Hormone Sensitive Prostate Cancer

## Interventions

- **RADIATION:** Para Aortic Radiation Therapy: Photon Therapy
- **RADIATION:** Para Aortic Radiation Therapy: Proton Therapy
- **DRUG:** Androgen Deprivation Therapy
- **DRUG:** Androgen Receptor Signaling Inhibitor

## Key facts

- **NCT ID:** NCT06392295
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-03
- **Primary completion:** 2027-08-01
- **Final completion:** 2029-08-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06392295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06392295, "PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06392295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*